You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

Generic Companies with Tentative Approvals for: Msn


✉ Email this page to a colleague

« Back to Dashboard


Msn Generic Filers with Tentative Approvals

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Applicant Generic Name NDA Strength Dosage Form
Msn Pharmaceuticals Inc afatinib 210804 40MG TABLET;ORAL
Msn Laboratories Private Ltd levomilnacipran 210805 120MG CAPSULE, EXTENDED RELEASE;ORAL
Msn Laboratories Private Ltd brivaracetam 214924 50MG/5ML (10MG/ML) SOLUTION;INTRAVENOUS
Msn Pharmaceuticals Inc carfilzomib 209526 10MG INJECTABLE;INJECTION
Msn Pharmaceuticals Inc palbociclib 214758 100MG CAPSULE;ORAL
Msn Labs Pvt Ltd metformin hydrochloride 211479 10MG; 1GM TABLET, EXTENDED RELEASE; ORAL
Msn Laboratories Private Ltd alogliptin and metformin hydrochloride 210212 12.5MG/1000MG TABLET; ORAL
>Applicant >Generic Name >NDA >Strength >Dosage Form

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.